These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16635673

  • 1. A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis.
    Chung L, Fiorentino D.
    J Am Acad Dermatol; 2006 May; 54(5):880-2. PubMed ID: 16635673
    [Abstract] [Full Text] [Related]

  • 2. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.
    Engel G, Rockson SG.
    Vasc Med; 2005 Feb; 10(1):29-32. PubMed ID: 15920997
    [Abstract] [Full Text] [Related]

  • 3. Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept study.
    Roustit M, Gaillard-Bigot F, Blaise S, Stanke-Labesque F, Cracowski C, Seinturier C, Jourdil JF, Imbert B, Carpentier PH, Cracowski JL.
    Clin Pharmacol Ther; 2014 Apr; 95(4):439-45. PubMed ID: 24458011
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.
    Shah AA, Schiopu E, Chatterjee S, Csuka ME, Frech T, Goldberg A, Spiera R, Peng SL, McBride RJ, Cleveland JM, Steen V.
    J Rheumatol; 2016 Sep; 43(9):1665-71. PubMed ID: 27307535
    [Abstract] [Full Text] [Related]

  • 6. Preventive effect of an oral prostacyclin analog, beraprost sodium, on digital necrosis in systemic sclerosis. French Microcirculation Society Multicenter Group for the Study of Vascular Acrosyndromes.
    Vayssairat M.
    J Rheumatol; 1999 Oct; 26(10):2173-8. PubMed ID: 10529135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP, Diot E, Clerson P, Dupuis-Siméon F, Hachulla E, Hatron PY, Constans J, Cirstéa D, Farge-Bancel D, Carpentier PH.
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [Abstract] [Full Text] [Related]

  • 9. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J, Silver R.
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract] [Full Text] [Related]

  • 10. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A, Abou-Raya S, Helmii M.
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [Abstract] [Full Text] [Related]

  • 11. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients.
    Sebastiani M, Manfredi A, Colaci M, D'amico R, Malagoli V, Giuggioli D, Ferri C.
    Arthritis Rheum; 2009 May 15; 61(5):688-94. PubMed ID: 19405007
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.
    J Heart Lung Transplant; 2007 Nov 15; 26(11):1079-83. PubMed ID: 18022071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Digital ulcers in patients with systemic sclerosis.
    Chung L, Fiorentino D.
    Autoimmun Rev; 2006 Feb 15; 5(2):125-8. PubMed ID: 16431342
    [Abstract] [Full Text] [Related]

  • 15. [Digital ulcers in systemic sclerosis].
    Prus V.
    Reumatizam; 2010 Feb 15; 57(2):115-7. PubMed ID: 21875016
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study.
    Sebastiani M, Manfredi A, Vukatana G, Moscatelli S, Riato L, Bocci M, Iudici M, Principato A, Mazzuca S, Del Medico P, De Angelis R, D'Amico R, Vicini R, Colaci M, Ferri C.
    Ann Rheum Dis; 2012 Jan 15; 71(1):67-70. PubMed ID: 21917823
    [Abstract] [Full Text] [Related]

  • 18. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
    Chamaillard M, Heliot-Hosten I, Constans J, Taïeb A.
    Arch Dermatol; 2007 Jan 15; 143(1):125-6. PubMed ID: 17224564
    [No Abstract] [Full Text] [Related]

  • 19. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion.
    Shah AA, Schiopu E, Hummers LK, Wade M, Phillips K, Anderson C, Wise R, Boin F, Seibold JR, Wigley F, Rollins KD.
    Arthritis Res Ther; 2013 Apr 18; 15(2):R54. PubMed ID: 23597147
    [Abstract] [Full Text] [Related]

  • 20. Management of digital ulcers related to systemic sclerosis.
    Brown S.
    Nurs Stand; 2013 Apr 18; 24(32):53-4, 56, 58 passim. PubMed ID: 20461945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.